LyondellBasell Up 16% in a Month, Shorts Retreat Before Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
LYB has gained 16% over the past month and 5.7% in the past week, moving sharply against a peer median of -0.4%, as short sellers reduce exposure ahead of Thursday's Q3 report. Short interest has fallen 14.6% over the past month to 3.7% of the free float, with another small drop recorded on October 23. Borrowing costs are negligible at 0.44%, and availability is essentially unconstrained, confirming that the retreat in shorts reflects conviction rather than a forced cover. The put/call ratio at 1.42 remains elevated in absolute terms but is running about one standard deviation below its 20-day average of 1.53, which itself sits well above typical levels, suggesting options positioning has grown less defensive even as the underlying structure stays cautious.
The stock's rally has made the analyst debate tighter than it was a month ago. RBC Capital maintained its Outperform but cut its target from $72 to $68 on October 13, the same day Barclays initiated at Equal-Weight with a $66 target. Citigroup had already downgraded to Neutral at the end of September, slashing its target from $72 to $63. The consensus mean sits at $68.89, barely above the current price of $67.35, which means the stock has largely caught up to where the Street thought fair value was before the recent run. The forward earnings yield ranks in the 77th percentile and the 12-month forward EPS estimate trend scores in the 77th percentile as well, giving bulls a valuation and estimate-revision case to hold onto. Bears point to a 53% drop in North American olefins and polyolefins output, persistent oversupply in oxyfuels, and deteriorating styrene margins as evidence that the recovery story is thinner than the share price implies.
The ownership picture adds an unusual dimension. LYB Holdco LLC, affiliated with Access Industries, holds a 20.3% Schedule 13D stake, making it a registered activist on the SEC's EDGAR record. The position was last reported unchanged as of June 2025. As with all 13D/G disclosures, the stake is as last filed and reflects conditions around the 5% reporting threshold; the holder could have adjusted without triggering a fresh filing. BlackRock added 4.2 million shares in the quarter ended September 30, bringing its holding to 9.1% of shares. Davis Selected Advisers added 3.1 million shares in the same period. The accumulation by two significant active managers into a quarter that saw the stock near its lows gives the bull case a structural support layer.
Most recently, DOW, LYB's highest-correlated peer at 91%, gained 13% on the week and 4.2% on Monday alone, a move that likely pulled LYB along and may have compressed some of the short position mechanically. The Q3 print on October 30 will test whether the margin recovery in the O&P segment has made enough progress to justify a share price that now sits at the top end of the analyst target range, at a moment when the Street has just spent four weeks cutting those targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open LYB on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:15
- Data as of
- 27 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.